Delivery Order SPE2DB24D8003-SPE2DB24FJTLR
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $3,351.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a range of pharmaceutical products, medical supplies,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product Mounjaro 15 mg/0.5 ml pen. The $3,869.65 contract has a completion date of July 2, 2025 and is not a set-aside award. Dakota Drug, Inc. is a key supplier of medical products and pharmaceuticals to the U.S. Armed Forces, having been awarded a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $3,689.76 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This order is part of Dakota Drug's $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and simulation equipment for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,215.04 firm fixed price delivery order is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML, with a completion date of May 30, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,504.35 contract is for the supply of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical products,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $9,080.31 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4559106710 MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract is part of the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. Dakota Drug, Inc. holds a...
- This federal contract award, valued at $3,095.34, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, worth $999,999,999.00. The IDC falls under the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $1,035.87, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through February 6, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJTQK, was granted by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,972.10. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure, and an ultimate completion date of January 13, 2025. Dakota Drug, Inc. is a key supplier...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,511.38, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of March 14, 2025. Dakota Drug, Inc. is also the holder of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB24FJTLRDelivery Order
This federal contract award, valued at $2,694.90, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a delivery order for the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of August 30, 2024 and is structured as a firm fixed-price agreement. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations under the DLA Troop Support Medical's ECAT Generation V Program. This position as a key supplier to the DLA's military medical supply programs demonstrates Dakota Drug, Inc.'s importance in the agency's efforts to efficiently procure essential medical items for various defense healthcare facilities and operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/29/24 |